Ocugen, Inc.
OCGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001372299
In the last 90 days, Ocugen, Inc. insiders filed 0 open-market purchases and 1 sale; 147 institutions reported holding it in 13F filings for Q2 2026, worth $222.1M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Ocugen, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +21 vs. Q1 2024
- Shares held
- 67.4M
- +34.4M (+104.5%) vs. Q1 2024
- Total value
- $104.4M
- +$50.4M (+93.5%) vs. Q1 2024
- New holders
- 44
- 25 more added
- Sold out
- 23
- 11 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 147 | $222.1M |
| Q1 2026 | 137 | $200.5M |
| Q4 2025 | 109 | $82.2M |
| Q3 2025 | 97 | $74.8M |
| Q2 2025 | 104 | $50.1M |
| Q1 2025 | 110 | $54.2M |
| Q4 2024 | 114 | $57.7M |
| Q3 2024 | 115 | $79.1M |
| Q2 2024 | 101 | $104.4M |
| Q1 2024 | 81 | $54.0M |
| Q4 2023 | 68 | $15.1M |
| Q3 2023 | 78 | $13.2M |
| Q2 2023 | 96 | $26.5M |
| Q1 2023 | 103 | $53.2M |
| Q4 2022 | 114 | $117.0M |
| Q3 2022 | 128 | $146.5M |
| Q2 2022 | 124 | $193.1M |
| Q1 2022 | 122 | $279.2M |
| Q4 2021 | 122 | $291.2M |
| Q3 2021 | 116 | $396.4M |
| Q2 2021 | 129 | $455.7M |
| Q1 2021 | 82 | $167.3M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Ocugen, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 17,920,187 | $27.8M | 0.00% | +14,120,947+371.7% | Added |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,925,755−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −806,500−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −366,940−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −143,393−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −128,825−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −110,836−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −98,390−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −69,268−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −67,400−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −62,800−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −80,676−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −40,198−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −33,960−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −24,200−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −23,528−100.0% | Sold out |
| Lanham O'Dell & Company, Inc. | 0 | $0 | 0.00% | −23,050−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −18,100−100.0% | Sold out |
| Symmetry Investments LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −13,962−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −336−100.0% | Sold out |
| Vima LLC | 0 | $0 | 0.00% | −365−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −5,883−100.0% | Sold out |
| Retirement Group, LLC | – | – | – | – | Not filed |